Viral pandemic preparedness: A pluripotent stem cell-based machine-learning platform for simulating SARS-CoV-2 infection to enable drug discovery and repurposing.

Abstract excerpt

Infection with the SARS-CoV-2 virus has rapidly become a global pandemic for which we were not prepared. Several clinical trials using previously approved drugs and drug combinations are urgently under way to improve the current situation. A vaccine option has only recently become available, but worldwide distribution is still a challenge. It is imperative that, for future viral pandemic preparedness, we have a...

Topics

Join the communities discussing this publication.

• Alveolar Epithelial Cells
• COVID-19 Drug Treatment
• Drug Discovery
• Drug Industry
• Drug Repositioning